SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 of 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported) May 16, 2002
INTERNATIONAL BIOCHEMICAL INDUSTRIES, INC.
formerly
BIOSHEILD TECHNOLOGIES, INC.
----------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Georgia 0-24913 58-2181628
---------------------------- ------------------------ --------------------
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification Number)
4505 International Boulevard, Suite B-109, Norcross, Georgia 30093
----------------------------------------
(Address of Principal Executive Offices)
Registrant's telephone number, including area
code: 770-925-3653
Item 5. Other Events
On June 6, 2002 the Company filed a Form 8-K with date of Report of May 16,
2002, wherein it reported under Item 5, the entry into a Letter Agreement
("Agreement") with a firm known as Aerus. The Agreement indicated, in part, that
the due diligence process provided for was expected to be concluded on or before
September 16, 2002. A copy of the Letter Agreement was filed as Exhibit 99 to
such Form 8-K.
The due diligence period having ended, the parties thereto have mutually agreed
not to go forward with the proposed transaction.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
INTERNATIONAL BIOCHEMICAL
INDUSTRIES, INC.
By: /Timothy C. Moses/
------------------------------------
Timothy C. Moses
President and Chief Executive Officer
Dated: October 7, 2002